France – La guerre du paracétamol est déclarée entre les pharmaciens et le groupe...
Le thermomètre grimpe entre E.Leclerc et les pharmaciens. La dernière campagne publicitaire de l’industriel de la grande distribution, qui remet en cause le monopole...
UK – NHS rolls out 5-minute ‘super-jab’ for 15 cancers
The health service is rolling out an injectable form of immunotherapy, nivolumab, which means patients can receive their fortnightly or monthly treatment in 5...
Europe – New treatment against Duchenne muscular dystrophy
EMA has recommended granting a conditional marketing authorisation in the European Union (EU) for Duvyzat (givinostat) as a treatment for Duchenne muscular dystrophy (DMD) in patients...
UK – MHRA approves first UK treatment for Friedreich’s ataxia, omaveloxolone
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 23 April, approved omaveloxolone (Skyclarys), the first treatment for patients aged 16 and over,...
Europe – First treatment against severe thyroid eye disease
EMA has recommended granting a marketing authorisation in the European Union (EU) for Tepezza (teprotumumab), for the treatment of adults with moderate to severe thyroid eye...
UK – BMS receives NICE recommendation for immunotherapy combination in colorectal cancer
The health technology assessment agency has recommended in final draft guidance that Opdivo (nivolumab) plus Yervoy (ipilimumab) be used on the NHS in England,...
International – ICH releases overhauled stability guideline for consultation
The International Council for Harmonisation (ICH) on 17 April issued its long-awaited update of its Q1 guideline on stability testing of drug substances and...
UK – AstraZeneca’s Truqap recommended by NICE to treat advanced breast cancer
The health technology assessment agency has recommended in final draft guidance that the drug be used in combination with AZ’s endocrine therapy Faslodex (fulvestrant)...
Europe – Revised general chapters for elemental analysis published in Pharmeuropa 37.2
Analytical procedures for elemental analysis are described in the following European Pharmacopoeia (Ph. Eur.) general chapters:
2.2.22. Atomic emission spectrometry;
2.2.23. Atomic absorption spectrometry;
...
USA – FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies...
Today, the U.S. Food and Drug Administration is taking a groundbreaking step to advance public health by replacing animal testing in the development of...
